An adapted mindfulness training program improve interoception and adherence to the DASH diet.
Blockbuster cancer drug Calquence hits primary endpoint in trial for first-line mantle cell lymphoma
AstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell lymphoma, releasing what it calls positive interim results from a